Form 4: Zura Bio Ltd: Chief Technology Officer Acquires 280,000 Employee Share Options
SEC Form 4 Filing
Gary Whale, Chief Technology Officer of Zura Bio Ltd, reports the acquisition of 280,000 employee share options.
Summary
- Gary Whale, the Chief Technology Officer of Zura Bio Ltd, filed a Form 4 on June 21, 2024, reporting a transaction.
- On June 18, 2024, Whale acquired 280,000 employee share options with an exercise price of $3.38.
- These options vest over time, with one-fourth vesting on June 18, 2025, and the remainder vesting in equal quarterly installments thereafter, contingent upon continuous service.
- The options expire on June 18, 2034.
- Following the reported transaction, Whale directly owns 280,000 derivative securities.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing related to stock options, indicating a neutral sentiment. It reflects typical executive compensation practices.
Positives
- The granting of employee share options can align the interests of the CTO with those of the shareholders.
- The vesting schedule incentivizes continued service and contribution to the company.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the options.
Industry Context
This filing is a routine disclosure related to executive compensation and is common in publicly traded companies to ensure transparency regarding insider transactions.
Comparison to Industry Standards
- Employee stock options are a standard form of compensation for executives in publicly traded companies, particularly in the biotech and pharmaceutical industries.
- Vesting schedules are also common, designed to retain key personnel and align their interests with long-term company performance.
- The specific terms of the option grant (exercise price, vesting schedule, expiration date) would need to be compared to similar grants at comparable companies to assess its competitiveness.
Stakeholder Impact
- Shareholders may view the granting of stock options as a way to align management's interests with the company's long-term success.
- Employees, particularly the CTO, are incentivized to contribute to the company's growth and value creation.
Key Dates
| Date | Description |
|---|---|
| 06/18/2024 | Date of transaction: Acquisition of employee share options. |
| 06/18/2025 | Initial vesting date: One-fourth of the shares subject to the option award vest. |
| 06/18/2034 | Expiration date of the employee share options. |
| 06/21/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.